Chronic cystitis

Summary

Chronic cystitis (MONDO:0006030) is a disease and 3 clinical trials. Top therapeutic interventions include oxygen and d-mannose. A subtype of cystitis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Clinical trials: 3

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	chronic cystitis
Mondo ID	MONDO:0006030
EFO	EFO:1000023
DOID	DOID:1680
NCIT	C27008
SNOMED CT	33655002
UMLS	C0221763
MedGen	65146
Is cancer (heuristic)	no

Also known as: cystitis, chronic

Disease family

This is a subtype of cystitis. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › urinary system disorder › urinary bladder disorder › cystitis › chronic cystitis

Related subtypes (13): hemorrhagic cystitis, prostatocystitis, acute cystitis, diphtheritic cystitis, trigonitis, radiation cystitis, cystitis cystica, emphysematous cholecystitis, acalculous cholecystitis, gonococcal cystitis, pyelocystitis, eosinophilic cryptitis, Trichomonas cystitis

Subtypes (2): glandular cystitis, interstitial cystitis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 3.

Phase distribution (across all retrieved trials)

Phase	Trials
PHASE4	1
PHASE3	1
Not specified	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT07240649	PHASE4	NOT_YET_RECRUITING	Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications
NCT06284265	PHASE3	ACTIVE_NOT_RECRUITING	Clinical Trial of the Efficacy and Safety of Raphamin in Prevention of Recurrences of Chronic Bacterial Cystitis
NCT06940622	Not specified	RECRUITING	A Trial of D-mannose for the Prophylaxis of Recurrent Urinary Tract Infections

Drugs tested across these trials (top 30)

Molecule	Max phase	Trials referencing
OXYGEN	4	1
D-MANNOSE	2	1
CHEMBL195368	0	1
CHEMBL365590	0	1